Cargando…
Gorlin syndrome-induced pluripotent stem cells form medulloblastoma with loss of heterozygosity in PTCH1
Gorlin syndrome is a rare autosomal dominant hereditary disease with a high incidence of tumors such as basal cell carcinoma and medulloblastoma. Disease-specific induced pluripotent stem cells (iPSCs) and an animal model have been used to analyze disease pathogenesis. In this study, we generated iP...
Autores principales: | Ikemoto, Yu, Miyashita, Toshiyuki, Nasu, Michiyo, Hatsuse, Hiromi, Kajiwara, Kazuhiro, Fujii, Katsunori, Motojima, Toshino, Kokido, Ibuki, Toyoda, Masashi, Umezawa, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288908/ https://www.ncbi.nlm.nih.gov/pubmed/32436863 http://dx.doi.org/10.18632/aging.103258 |
Ejemplares similares
-
PTCH1-null induced pluripotent stem cells exclusively differentiate into immature ectodermal cells with large areas of medulloblastoma-like tissue
por: Nagao, Kazuaki, et al.
Publicado: (2022) -
NFB-09. Treatment of cardiac fibroma in aPTCH1-mutated Gorlin syndrome with medulloblastoma
por: Piccolo, Gianluca, et al.
Publicado: (2022) -
A novel PTCH1 mutation in a patient with Gorlin syndrome
por: Okamoto, Nana, et al.
Publicado: (2014) -
PTCH2 is not a strong candidate gene for gorlin syndrome predisposition
por: Smith, Miriam J., et al.
Publicado: (2021) -
Novel PTCH1 Gene Mutation in a Patient with Gorlin–Goltz Syndrome
por: Ozlu, Emin, et al.
Publicado: (2019)